Document Type and Number:
Japanese Patent JPWO2023027198
Kind Code:
A1
Abstract:
The present invention provides a formulation for oral administration, comprising a triazine derivative having virus proliferation inhibitory action.
Application Number:
JP2022574839A
Publication Date:
March 02, 2023
Filing Date:
November 22, 2022
Export Citation:
